Le diagnostic repose sur les symptômes cliniques et peut être confirmé par un test PCR.
GrippeDiagnostic médical
#2
Quels tests sont utilisés pour détecter le virus de la grippe ?
Les tests rapides, la culture virale et la PCR sont couramment utilisés.
Tests de diagnosticVirus de la grippe
#3
Quand faut-il envisager un traitement par zanamivir ?
Le traitement par zanamivir est envisagé dans les 48 heures suivant l'apparition des symptômes.
ZanamivirGrippe
#4
Quels sont les signes cliniques de la grippe ?
Fièvre, toux, douleurs musculaires, fatigue et maux de tête sont des signes courants.
Symptômes de la grippeGrippe
#5
Le zanamivir est-il efficace contre tous les types de grippe ?
Il est principalement efficace contre les virus de la grippe A et B, mais pas contre tous.
ZanamivirVirus de la grippe
Symptômes
5
#1
Quels sont les symptômes de la grippe ?
Les symptômes incluent fièvre, toux, douleurs corporelles, fatigue et mal de gorge.
Symptômes de la grippeGrippe
#2
La grippe peut-elle provoquer des complications ?
Oui, elle peut entraîner des complications comme la pneumonie ou des exacerbations d'asthme.
Complications de la grippePneumonie
#3
Les symptômes de la grippe sont-ils similaires à ceux d'un rhume ?
Oui, mais la grippe est généralement plus sévère et s'accompagne de fièvre élevée.
GrippeRhume
#4
Comment différencier la grippe d'un rhume ?
La grippe provoque des symptômes plus intenses et une apparition soudaine par rapport au rhume.
GrippeDiagnostic médical
#5
Les symptômes de la grippe durent-ils longtemps ?
En général, les symptômes durent de 5 à 7 jours, mais la fatigue peut persister.
Durée des symptômesGrippe
Prévention
5
#1
Comment prévenir la grippe ?
La vaccination annuelle et l'hygiène des mains sont essentielles pour prévenir la grippe.
Prévention de la grippeVaccination
#2
Le zanamivir peut-il être utilisé comme prophylaxie ?
Oui, il peut être administré en prophylaxie après exposition au virus de la grippe.
ZanamivirProphylaxie
#3
Quelles sont les recommandations pour éviter la grippe ?
Éviter les foules, se laver les mains régulièrement et porter un masque en cas d'épidémie.
Prévention de la grippeHygiène
#4
La vaccination est-elle efficace contre la grippe ?
Oui, la vaccination réduit le risque d'infection et les complications graves liées à la grippe.
VaccinationGrippe
#5
Quand se faire vacciner contre la grippe ?
Il est recommandé de se faire vacciner avant le début de la saison grippale, généralement en automne.
VaccinationPrévention de la grippe
Traitements
5
#1
Comment le zanamivir agit-il contre la grippe ?
Il inhibe l'enzyme neuraminidase, empêchant la libération de nouveaux virus dans l'organisme.
ZanamivirMécanisme d'action
#2
Quelles sont les voies d'administration du zanamivir ?
Le zanamivir est administré par inhalation, ce qui permet une action directe dans les voies respiratoires.
ZanamivirVoies d'administration
#3
Le zanamivir est-il sûr pour les enfants ?
Oui, il est approuvé pour les enfants de plus de 7 ans, mais doit être utilisé avec précaution.
ZanamivirEnfants
#4
Quels sont les effets secondaires du zanamivir ?
Les effets secondaires peuvent inclure des réactions respiratoires, des nausées et des diarrhées.
Effets secondairesZanamivir
#5
Le zanamivir peut-il être utilisé en prévention ?
Oui, il peut être utilisé pour prévenir la grippe chez les personnes exposées au virus.
Prévention de la grippeZanamivir
Complications
5
#1
Quelles sont les complications possibles de la grippe ?
Les complications incluent la pneumonie, la bronchite et des aggravations d'affections chroniques.
Complications de la grippePneumonie
#2
Qui est à risque de complications graves ?
Les personnes âgées, les jeunes enfants et celles avec des maladies chroniques sont à risque.
Facteurs de risqueComplications de la grippe
#3
Comment prévenir les complications de la grippe ?
La vaccination, un traitement précoce et une bonne hygiène peuvent aider à prévenir les complications.
Prévention de la grippeComplications
#4
Les complications de la grippe peuvent-elles être mortelles ?
Oui, surtout chez les populations vulnérables, les complications peuvent être fatales.
Complications de la grippeMortalité
#5
Quels sont les signes d'une complication de la grippe ?
Une aggravation des symptômes, des difficultés respiratoires ou une douleur thoracique peuvent indiquer une complication.
Complications de la grippeSymptômes
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour la grippe ?
Les facteurs incluent l'âge, les maladies chroniques, la grossesse et un système immunitaire affaibli.
Facteurs de risqueGrippe
#2
Les personnes âgées sont-elles plus à risque de grippe ?
Oui, les personnes âgées ont un risque accru de complications graves liées à la grippe.
Personnes âgéesGrippe
#3
Les enfants sont-ils plus vulnérables à la grippe ?
Oui, les jeunes enfants sont plus susceptibles de contracter la grippe et de développer des complications.
EnfantsGrippe
#4
Le diabète augmente-t-il le risque de grippe ?
Oui, les personnes atteintes de diabète ont un risque accru de complications grippales.
DiabèteFacteurs de risque
#5
Les personnes immunodéprimées sont-elles à risque ?
Oui, elles sont plus susceptibles de contracter la grippe et de développer des complications graves.
ImmunodépressionGrippe
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Zanamivir : Questions médicales les plus fréquentes",
"headline": "Zanamivir : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Zanamivir : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-10",
"dateModified": "2026-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Zanamivir"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Acides sialiques",
"url": "https://questionsmedicales.fr/mesh/D012794",
"about": {
"@type": "MedicalCondition",
"name": "Acides sialiques",
"code": {
"@type": "MedicalCode",
"code": "D012794",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.811.589.668"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Zanamivir",
"alternateName": "Zanamivir",
"code": {
"@type": "MedicalCode",
"code": "D053243",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Helen A Watson",
"url": "https://questionsmedicales.fr/author/Helen%20A%20Watson",
"affiliation": {
"@type": "Organization",
"name": "GlaxoSmithKline, Stockley Park, United Kingdom."
}
},
{
"@type": "Person",
"name": "Amanda Peppercorn",
"url": "https://questionsmedicales.fr/author/Amanda%20Peppercorn",
"affiliation": {
"@type": "Organization",
"name": "Clinical Development, GSK, Boston, Massachusetts, USA."
}
},
{
"@type": "Person",
"name": "Sadhana S Kode",
"url": "https://questionsmedicales.fr/author/Sadhana%20S%20Kode",
"affiliation": {
"@type": "Organization",
"name": "Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, Pune, India."
}
},
{
"@type": "Person",
"name": "Shailesh D Pawar",
"url": "https://questionsmedicales.fr/author/Shailesh%20D%20Pawar",
"affiliation": {
"@type": "Organization",
"name": "Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, Pune, India. Electronic address: shaileshpawarniv@gmail.com."
}
},
{
"@type": "Person",
"name": "Deeksha S Tare",
"url": "https://questionsmedicales.fr/author/Deeksha%20S%20Tare",
"affiliation": {
"@type": "Organization",
"name": "Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, Pune, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States: 2019 update.",
"datePublished": "2023-09-03",
"url": "https://questionsmedicales.fr/article/37661338",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jhm.13194"
}
},
{
"@type": "ScholarlyArticle",
"name": "In-Hospital Triage.",
"datePublished": "2024-04-16",
"url": "https://questionsmedicales.fr/article/38796226",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ccc.2024.03.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analyses of hospitalization in Alzheimer's disease and Parkinson's disease in a tertiary hospital.",
"datePublished": "2023-05-04",
"url": "https://questionsmedicales.fr/article/37213636",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1159110"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Discover In-Hospital Cardiac Arrest (Discover IHCA) Study: An Investigation of Hospital Practices After In-Hospital Cardiac Arrest.",
"datePublished": "2024-09-11",
"url": "https://questionsmedicales.fr/article/39258957",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CCE.0000000000001149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost and time of hospitalization for elderly people with bone fractures in a reference hospital.",
"datePublished": "2024-07-26",
"url": "https://questionsmedicales.fr/article/39082508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31744/einstein_journal/2024GS0493"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Glucides",
"item": "https://questionsmedicales.fr/mesh/D002241"
},
{
"@type": "ListItem",
"position": 3,
"name": "Oses acides",
"item": "https://questionsmedicales.fr/mesh/D013400"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides neuraminiques",
"item": "https://questionsmedicales.fr/mesh/D009438"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides sialiques",
"item": "https://questionsmedicales.fr/mesh/D012794"
},
{
"@type": "ListItem",
"position": 6,
"name": "Zanamivir",
"item": "https://questionsmedicales.fr/mesh/D053243"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Zanamivir - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Zanamivir",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Zanamivir",
"description": "Comment diagnostiquer une infection grippale ?\nQuels tests sont utilisés pour détecter le virus de la grippe ?\nQuand faut-il envisager un traitement par zanamivir ?\nQuels sont les signes cliniques de la grippe ?\nLe zanamivir est-il efficace contre tous les types de grippe ?",
"url": "https://questionsmedicales.fr/mesh/D053243?mesh_terms=Hospitalization#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Zanamivir",
"description": "Quels sont les symptômes de la grippe ?\nLa grippe peut-elle provoquer des complications ?\nLes symptômes de la grippe sont-ils similaires à ceux d'un rhume ?\nComment différencier la grippe d'un rhume ?\nLes symptômes de la grippe durent-ils longtemps ?",
"url": "https://questionsmedicales.fr/mesh/D053243?mesh_terms=Hospitalization#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Zanamivir",
"description": "Comment prévenir la grippe ?\nLe zanamivir peut-il être utilisé comme prophylaxie ?\nQuelles sont les recommandations pour éviter la grippe ?\nLa vaccination est-elle efficace contre la grippe ?\nQuand se faire vacciner contre la grippe ?",
"url": "https://questionsmedicales.fr/mesh/D053243?mesh_terms=Hospitalization#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Zanamivir",
"description": "Comment le zanamivir agit-il contre la grippe ?\nQuelles sont les voies d'administration du zanamivir ?\nLe zanamivir est-il sûr pour les enfants ?\nQuels sont les effets secondaires du zanamivir ?\nLe zanamivir peut-il être utilisé en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D053243?mesh_terms=Hospitalization#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Zanamivir",
"description": "Quelles sont les complications possibles de la grippe ?\nQui est à risque de complications graves ?\nComment prévenir les complications de la grippe ?\nLes complications de la grippe peuvent-elles être mortelles ?\nQuels sont les signes d'une complication de la grippe ?",
"url": "https://questionsmedicales.fr/mesh/D053243?mesh_terms=Hospitalization#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Zanamivir",
"description": "Quels sont les facteurs de risque pour la grippe ?\nLes personnes âgées sont-elles plus à risque de grippe ?\nLes enfants sont-ils plus vulnérables à la grippe ?\nLe diabète augmente-t-il le risque de grippe ?\nLes personnes immunodéprimées sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D053243?mesh_terms=Hospitalization#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection grippale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes cliniques et peut être confirmé par un test PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter le virus de la grippe ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests rapides, la culture virale et la PCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager un traitement par zanamivir ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement par zanamivir est envisagé dans les 48 heures suivant l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques de la grippe ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, douleurs musculaires, fatigue et maux de tête sont des signes courants."
}
},
{
"@type": "Question",
"name": "Le zanamivir est-il efficace contre tous les types de grippe ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est principalement efficace contre les virus de la grippe A et B, mais pas contre tous."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la grippe ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleurs corporelles, fatigue et mal de gorge."
}
},
{
"@type": "Question",
"name": "La grippe peut-elle provoquer des complications ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications comme la pneumonie ou des exacerbations d'asthme."
}
},
{
"@type": "Question",
"name": "Les symptômes de la grippe sont-ils similaires à ceux d'un rhume ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais la grippe est généralement plus sévère et s'accompagne de fièvre élevée."
}
},
{
"@type": "Question",
"name": "Comment différencier la grippe d'un rhume ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La grippe provoque des symptômes plus intenses et une apparition soudaine par rapport au rhume."
}
},
{
"@type": "Question",
"name": "Les symptômes de la grippe durent-ils longtemps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, les symptômes durent de 5 à 7 jours, mais la fatigue peut persister."
}
},
{
"@type": "Question",
"name": "Comment prévenir la grippe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination annuelle et l'hygiène des mains sont essentielles pour prévenir la grippe."
}
},
{
"@type": "Question",
"name": "Le zanamivir peut-il être utilisé comme prophylaxie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être administré en prophylaxie après exposition au virus de la grippe."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour éviter la grippe ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les foules, se laver les mains régulièrement et porter un masque en cas d'épidémie."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace contre la grippe ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination réduit le risque d'infection et les complications graves liées à la grippe."
}
},
{
"@type": "Question",
"name": "Quand se faire vacciner contre la grippe ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de se faire vacciner avant le début de la saison grippale, généralement en automne."
}
},
{
"@type": "Question",
"name": "Comment le zanamivir agit-il contre la grippe ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il inhibe l'enzyme neuraminidase, empêchant la libération de nouveaux virus dans l'organisme."
}
},
{
"@type": "Question",
"name": "Quelles sont les voies d'administration du zanamivir ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le zanamivir est administré par inhalation, ce qui permet une action directe dans les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Le zanamivir est-il sûr pour les enfants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est approuvé pour les enfants de plus de 7 ans, mais doit être utilisé avec précaution."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires du zanamivir ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions respiratoires, des nausées et des diarrhées."
}
},
{
"@type": "Question",
"name": "Le zanamivir peut-il être utilisé en prévention ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé pour prévenir la grippe chez les personnes exposées au virus."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la grippe ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, la bronchite et des aggravations d'affections chroniques."
}
},
{
"@type": "Question",
"name": "Qui est à risque de complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les jeunes enfants et celles avec des maladies chroniques sont à risque."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications de la grippe ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, un traitement précoce et une bonne hygiène peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications de la grippe peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surtout chez les populations vulnérables, les complications peuvent être fatales."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une complication de la grippe ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une aggravation des symptômes, des difficultés respiratoires ou une douleur thoracique peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la grippe ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les maladies chroniques, la grossesse et un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de grippe ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de complications graves liées à la grippe."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables à la grippe ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants sont plus susceptibles de contracter la grippe et de développer des complications."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il le risque de grippe ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de diabète ont un risque accru de complications grippales."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus susceptibles de contracter la grippe et de développer des complications graves."
}
}
]
}
]
}
Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, Pune, India. Electronic address: shaileshpawarniv@gmail.com.
Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electronic address: arikd@bgu.ac.il.
Department of Medical and Surgical Sciences, Infectious and Tropical Diseases Unit, "Magna Graecia" University of Catanzaro, Catanzaro, Italy. torti@unicz.it.
General hospitals (GH) provide inpatient care for the majority of hospitalized children in the United States, yet the majority of hospital pediatrics research is conducted at freestanding children's h...
Updating a prior 2012 analysis, this study used 2019 data to describe characteristics of pediatric hospitalizations at general and freestanding hospitals in the United States and identify the most com...
This study examined hospitalizations in children <18 years using the Healthcare Cost and Utilization Project's 2019 Kids' Inpatient Database, stratifying neonatal and nonneonatal hospital stays....
Not applicable....
Sociodemographic and clinical differences between hospitalizations at general and freestanding children's hospitals were examined, applying survey weights to generate national estimates....
There were an estimated 5,263,218 pediatric hospitalizations in 2019, including 3,757,601 neonatal and 1,505,617 nonneonatal hospital stays. Overall, 88.6% (n = 4,661,288) of hospitalizations occurred...
The intensive care unit (ICU) is a finite and expensive resource with demand not infrequently exceeding capacity. Understanding ICU capacity strain is essential to gain situational awareness. Increase...
To characterize the pattern of hospitalization in patients with Alzheimer's disease (AD) or Parkinson's disease (PD), and compare the differences to see whether AD patients and PD patients have a diff...
The clinical features of all consecutive patients from January 2017 to December 2020 were reviewed. We identified AD patients and PD patients from an electronic database in a tertiary medical center....
The study group comprised 995 AD patients and 2,298 PD patients who were admitted to the hospital for the first time, and re-hospitalized 231 AD patients and 371 PD patients were also included. AD pat...
The present study found that AD patients and PD patients have a significantly different picture of hospitalization. It is important to implement different management for hospitalized AD and PD, and di...
In-hospital cardiac arrest (IHCA) is a significant public health burden. Rates of return of spontaneous circulation (ROSC) have been improving, but the best way to care for patients after the initial ...
Our study collects granular data on post-IHCA treatment practices, focusing on temperature control and prognostication, with the objective of describing variation in current post-IHCA practice....
This is a multicenter, prospectively collected, observational cohort study of patients who have suffered IHCA and have been successfully resuscitated (achieved ROSC). There are 24 enrolling hospital s...
The study collects data on patient characteristics including pre-arrest frailty, arrest characteristics, and detailed information on post-arrest practices and outcomes. Data collection on post-IHCA pr...
We expect this study, Discover IHCA, to identify variability in practice and outcomes following IHCA, and be a vital resource for future investigations into best-practice for managing patients after I...
To describe and analyze the aspects regarding the cost and length of stay for elderly patients with bone fractures in a tertiary reference hospital....
A cross-sectional retrospective study using data obtained from medical records between January and December 2020. For statistical analysis, exploratory analyses, Shapiro-Wilk test, χ2 test, and Spearm...
During the study period, 156 elderly patients (62.2% women) with bone fractures were treated. The main trauma mechanism was a fall from a standing height (76.9%). The most common type of fracture in t...
Fractures in the elderly are frequent, resulting in significant costs. The longer the hospital stay for treatment, the higher the total cost. No correlation was found between total cost and number of ...
Cleft lip or palate is a prevalent birth defect, occurring in approximately 1 to 2 per 1000 newborns and often necessitating numerous hospitalizations. Specific rates of hospitalization and complicati...
To assess the rates of airway infection-associated hospitalization, overall hospital admissions, in-hospital complications, and mortality among children with a cleft lip or palate....
This nationwide, population-based cohort study used in-hospital claims data from the Federal Statistical Office in Switzerland between 2012 and 2021. Participants included newborns with complete birth...
Prevalent diagnosis of a cleft lip or palate at birth....
Outcomes of interest were monthly hospitalization rates for airway infections and any cause during the first 2 years of life in newborns with cleft lip or palate. In-hospital outcomes and mortality ou...
Of 857 806 newborns included, 1197 (0.1%) had a cleft lip and/or palate, including 170 (14.2%) with a cleft lip only, 493 (41.2%) with a cleft palate only, and 534 (44.6%) with cleft lip and palate. N...
In this nationwide cohort study, the presence of cleft lip or palate was associated with increased hospitalization rates for respiratory infections and other causes, as well as poorer in-hospital outc...
Older adults who are hospitalized for COVID-19 are at risk of delirium. Little is known about the association of in-hospital delirium with functional and cognitive outcomes among older adults who have...
To evaluate the association of delirium with functional disability and cognitive impairment over the 6 months after discharge among older adults hospitalized with COVID-19....
This prospective cohort study involved patients aged 60 years or older who were hospitalized with COVID-19 between June 18, 2020, and June 30, 2021, at 5 hospitals in a major tertiary care system in t...
Delirium during the COVID-19 hospitalization was assessed using the Chart-based Delirium Identification Instrument (CHART-DEL) and CHART-DEL-ICU....
Primary outcomes were disability in 15 functional activities and the presence of cognitive impairment (defined as Montreal Cognitive Assessment score <22) at 1, 3, and 6 months after hospital discharg...
The cohort included 311 older adults (mean [SD] age, 71.3 [8.5] years; 163 female [52.4%]) who survived COVID-19 hospitalization. In the functional disability sample of 311 participants, 49 participan...
In this cohort study of 311 hospitalized older adults with COVID-19, in-hospital delirium was associated with increased functional disability and cognitive impairment over the 6 months following disch...
To compare hospitals that did and did not participate in clinical trials evaluating potential inpatient COVID-19 therapeutics....
We conducted a cross-sectional study of hospitals participating in trials that were registered on clinicaltrials.gov between April and August 2020. Using the 2019 RAND Hospital Dataset and 2019 Americ...
We included 488 hospitals that were participating in 298 interventional trials and 4232 non-participating hospitals. After controlling for demographic and other hospital traits, we found that teaching...
Hospitals participating and not participating in COVID-19 inpatient treatment clinical trials differed in many ways, resulting in important implications for the generalizability of trial data....
More than 70 000 Medicare beneficiaries receive care in long-term acute care hospitals (LTCHs) annually for prolonged acute illness. However, little is known about long-term functional and cognitive o...
To describe survival, functional, and cognitive status after LTCH hospitalization and to identify factors associated with an adverse outcome....
This retrospective cohort study included middle-aged and older adults enrolled in the Health and Retirement Study (HRS) with linked fee-for-service Medicare claims. Included participants were aged 50 ...
Function and cognition were ascertained from HRS interviews conducted every 2 years. The primary outcome was death or severe impairment in the 2.5 years after LTCH hospitalization, defined as dependen...
This study included 396 participants, with a median age of 75 (IQR, 68-82) years. Of the participants, 201 (51%) were women, 125 (28%) had severe impairment, and 318 (80%) died or survived with severe...
In this cohort study, 4 of 5 middle-aged and older adults died or survived with severe impairment within 2.5 years of LTCH hospitalization. Better preadmission survival prognosis and functional and co...
National analyses suggest that approximately 1 in 5 US hospitals closed their pediatric units between 2008 and 2018. The extent to which pediatric hospitalizations at general hospitals in rural and ur...
To describe changes in the number and proportion of pediatric hospitalizations and costs at urban teaching, urban nonteaching, and rural hospitals vs freestanding children's hospitals from 2009 to 201...
This study is a retrospective cross-sectional analysis of the 2009, 2012, 2016, and 2019 Kids' Inpatient Database, a nationally representative data set of US pediatric hospitalizations among children ...
Pediatric hospitalizations were grouped as birth or nonbirth hospitalizations. Hospitals were categorized as freestanding children's hospitals or as rural, urban nonteaching, or urban teaching general...
The primary outcomes were annual number and proportion of birth and nonbirth hospitalizations and health care costs, changes in the proportion of hospitalizations with complex diagnoses, and estimated...
The data included 23.2 million (95% CI, 22.7-23.6 million) weighted hospitalizations. From 2009 to 2019, estimated national annual pediatric hospitalizations decreased from 6 425 858 to 5 297 882, as ...
Between 2009 and 2019, the largest decreases in pediatric hospitalizations occurred at rural and urban nonteaching hospitals. Clinical and policy initiatives to support hospitals with low pediatric vo...